These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15299245)

  • 1. Tumor control probability for tumor therapy with beta radionuclide interstitial injection.
    Chen Y; Geng J; Tian J; He Y; Chen S
    Biomed Mater Eng; 2004; 14(3):333-5. PubMed ID: 15299245
    [No Abstract]   [Full Text] [Related]  

  • 2. A theoretical investigation into post-operative, intracavitary beta therapy of high-grade glioblastomas using yttrium-90.
    Stefanou SS; Sparks RB; Dale RG
    Phys Med Biol; 2006 Oct; 51(20):5377-89. PubMed ID: 17019045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):288-95. PubMed ID: 17043626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry in Peptide radionuclide receptor therapy: a review.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    J Nucl Med; 2006 Sep; 47(9):1467-75. PubMed ID: 16954555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of a TCP model incorporating population heterogeneity.
    Warkentin B; Stavrev P; Stavreva NA; Fallone BG
    Phys Med Biol; 2005 Aug; 50(15):3571-88. PubMed ID: 16030383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetry of beta nuclide filled balloon catheter in endovascular brachytherapy.
    Chen Y; Geng J; Tian J; Yin D; Chen S
    Biomed Mater Eng; 2004; 14(3):337-9. PubMed ID: 15299246
    [No Abstract]   [Full Text] [Related]  

  • 7. Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.
    Nayak TK; Norenberg JP; Anderson TL; Prossnitz ER; Stabin MG; Atcher RW
    Nucl Med Biol; 2007 Feb; 34(2):185-93. PubMed ID: 17307126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.
    Carlsson J; Eriksson V; Stenerlöw B; Lundqvist H
    Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1185-95. PubMed ID: 16718515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modified linear-quadratic model of Guerrero and Li can be derived from a mechanistic basis and exhibits linear-quadratic-linear behaviour.
    Carlone M; Wilkins D; Raaphorst P
    Phys Med Biol; 2005 May; 50(10):L9-13; author reply L13-5. PubMed ID: 15876677
    [No Abstract]   [Full Text] [Related]  

  • 10. Test of the local effect model using clinical data: tumour control probability for lung tumours after treatment with carbon ion beams.
    Scholz M; Matsufuji N; Kanai T
    Radiat Prot Dosimetry; 2006; 122(1-4):478-9. PubMed ID: 17145727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From imaging to dosimetry and biological effects.
    Konijnenberg M
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):44-56. PubMed ID: 21386784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
    Xiong W; Li J; Ma CM
    Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards biology-oriented treatment planning in hadrontherapy.
    Kundrát P
    Radiat Prot Dosimetry; 2006; 122(1-4):480-2. PubMed ID: 17169952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of dosimetry for Systemic Targeted Radionuclide Therapy (STaRT).
    Wessels BW; Syh JH; Meredith RF
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S39-45. PubMed ID: 16979438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple track structure model of ion beam radiotherapy.
    Waligórski MP; Hollmark M; Lesiak J
    Radiat Prot Dosimetry; 2006; 122(1-4):471-4. PubMed ID: 17127682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorbed fractions in ellipsoidal volumes for beta(-) radionuclides employed in internal radiotherapy.
    Amato E; Lizio D; Baldari S
    Phys Med Biol; 2009 Jul; 54(13):4171-80. PubMed ID: 19521004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
    Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
    Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment planning in molecular radiotherapy.
    Glatting G; Bardiès M; Lassmann M
    Z Med Phys; 2013 Dec; 23(4):262-9. PubMed ID: 23597414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the effect of clonogen resensitization on the tumor response to fractionated external radiotherapy.
    Stavreva NA; Warkentin B; Stavrev PV; Fallone BG
    Med Phys; 2005 Mar; 32(3):720-5. PubMed ID: 15839343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental validation of the new nanodosimetry-based cell survival model for mixed neutron and gamma-ray irradiation.
    Wang CK; Zhang X; Gifford I; Burgett E; Adams V; Al-Sheikhly M
    Phys Med Biol; 2007 Sep; 52(17):N367-74. PubMed ID: 17762072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.